Skip to main content

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.83
+3.52 (1.52%)
AAPL  249.64
+1.99 (0.80%)
AMD  254.47
+4.67 (1.87%)
BAC  52.87
+0.80 (1.54%)
GOOG  332.07
+3.69 (1.12%)
META  640.15
+27.19 (4.44%)
MSFT  449.72
+5.61 (1.26%)
NVDA  185.69
+2.38 (1.30%)
ORCL  178.26
+4.38 (2.52%)
TSLA  438.05
+6.61 (1.53%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.